secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001104659-24-068092
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Acura Pharmaceuticals CFO Peter Clemens to retire effective Sept 30; Robert Seiser appointed successor
--------------------------------------------------------------------------------

- Peter Clemens steps down as CFO on July 31, 2024, remains VP through Sept 30 for transition.
- Robert A. Seiser, currently VP Treasurer & Corporate Controller since 1998, appointed Sr. VP & CFO effective Aug 1, 2024.
- Board approved Clemens's retirement and Seiser's appointment on May 31, 2024.
- Clemens will continue as Vice President until end of September to ensure smooth handover.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/0001104659-24-068092-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465924068092/tm2416319d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-068092

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer